ロード中...
Alantolactone inhibits cervical cancer progression by downregulating BMI1
Cervical cancer is the second most common cancer in women. Despite advances in cervical cancer therapy, tumor recurrence and metastasis remain the leading causes of mortality. High expression of BMI1 is significantly associated with poor tumor differentiation, high clinical grade, and poor prognosis...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085045/ https://ncbi.nlm.nih.gov/pubmed/33927214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-87781-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|